The present invention relates to substituted ring fused azines and methods of using said compounds in treating cancers. More specifically, the present invention relates to the preparation of 4-alkyl-2-(heterocyclic)-azines and their use as cancer agents or drugs for cancer therapy. The compounds of the invention display favourable in vivo and in vitro activity against selected cancers.

 
Web www.patentalert.com

< METHOD OF CONVERTING FEEDSTOCKS FROM RENEWABLE SOURCES TO GOOD-QUALITY DIESEL FUEL BASES USING A ZEOLITE TYPE CATALYST

> Methods for detection of promoter polymorphism in a UGT gene promoter

> Small Interfering RNA Specific For HCV And Therapeutic Agent For Hepatitis C Comprising The Same

~ 00571